Also, the latter still possessed a small number of recipient-derived GM-CSF-producing ILCs (Figure 5D), indicating that reduction, if not complete abrogation, of GM-CSF production in ILCs was able to attenuate arthritis severity. The gene discussed is CSF2; the disease is arthritic joint disease.